Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus.
Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.
Ersoy
A
A
Department of Nephrology, Uludag University, Bursa, Turkey. alpersoy@uludag.edu.tr
Ersoy
C
C
Tekce
H
H
Yavascaoglu
I
I
Dilek
K
K
D000328:Adult; D016883:Diabetic Ketoacidosis / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011183:Postoperative Complications / Q000175:diagnosis*; D016559:Tacrolimus / Q000009:adverse effects*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus